ModivCare (MODV) 10-Q 6 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 03, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-34221
Entity Registrant Name	Providence Service Corp
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-0845127
Entity Address, Address Line One	1275 Peachtree Street
Entity Address, Address Line Two	Sixth Floor
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30309
City Area Code	404
Local Phone Number	888-5800
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	PRSC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		14,183,634
Entity Central Index Key	0001220754
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 183,277	$ 61,365
Accounts receivable, net of allowance of $2,794 and $5,933, respectively	164,944	180,416
Other receivables	7,310	3,396
Prepaid expenses and other	20,266	10,942
Restricted cash	3,182	153
Current assets of discontinued operations	357	155
Total current assets	379,336	256,427
Operating lease right-of-use assets	18,814	20,095
Property and equipment, net	21,048	23,243
Goodwill	135,216	135,216
Intangible assets, net	87,358	19,911
Equity investment	141,292	130,869
Other assets	8,571	11,620
Total assets	791,635	597,381
Current liabilities:
Current portion of finance lease liabilities	148	308
Accounts payable	26,677	9,805
Current portion of operating lease liabilities	6,680	6,730
Accrued expenses	143,033	38,733
Accrued transportation costs	81,558	87,063
Deferred revenue	681	227
Self-funded insurance programs	10,083	5,890
Current liabilities of discontinued operations	1,734	1,430
Total current liabilities	270,594	150,186
Finance lease liabilities, less current portion	0	45
Operating lease liabilities, less current portion	13,015	14,502
Long-term contract payables	50,244	0
Other long-term liabilities	12,195	15,029
Deferred tax liabilities	35,520	22,907
Total liabilities	381,568	202,669
Commitments and contingencies (Note 13)
Redeemable convertible preferred stock
Convertible preferred stock, net: Authorized 10,000,000 shares; $0.001 par value; 0 and 798,788, respectively, issued and outstanding; 5.5%/8.5% dividend rate	0	77,120
Stockholders’ equity
Common stock: Authorized 40,000,000 shares; $0.001 par value; 19,468,591 and 18,073,763, respectively, issued and outstanding (including treasury shares)	20	18
Additional paid-in capital	416,504	351,529
Retained earnings	221,509	183,733
Treasury shares, at cost, 5,285,666 and 5,088,782 shares, respectively	(227,966)	(217,688)
Total stockholders’ equity	410,067	317,592
Total liabilities, redeemable convertible preferred stock and stockholders’ equity	$ 791,635	$ 597,381

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Allowance for doubtful accounts	$ 2,794		$ 5,933
Temporary equity, shares authorized (in shares)	10,000,000		10,000,000
Temporary equity, par (in usd per share)	$ 0.001		$ 0.001
Temporary equity, shares issued (in shares)	0		0
Temporary equity, shares outstanding (in shares)	798,788		798,788
Common stock, shares authorized (in shares)	40,000,000		40,000,000
Common stock, par (in USD per share)	$ 0.001		$ 0.001
Common stock, shares, issued (in shares)	19,468,591		18,073,763
Common stock, shares, outstanding (in shares)	19,468,591		18,073,763
Treasury stock, shares (in shares)	5,285,666		5,088,782
Cash Dividends
Convertible preferred stock, dividend rate	5.50%
Paid-in-kind Dividends
Convertible preferred stock, dividend rate		8.50%

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Service revenue, net	$ 320,619	$ 393,385	$ 970,166	$ 1,125,111
Operating expenses:
Service expense	235,543	356,271	764,310	1,042,717
General and administrative expense	34,441	15,979	86,435	52,241
Depreciation and amortization	7,301	4,148	17,199	12,976
Total operating expenses	277,285	376,398	867,944	1,107,934
Operating income	43,334	16,987	102,222	17,177
Other expenses (income):
Interest expense, net	379	188	2,118	793
Other income	0	(66)	0	(199)
Equity in net (income) loss of investee	(10,325)	3,188	(12,200)	6,159
Income from continuing operations before income taxes	53,280	13,677	112,304	10,424
Provision for income taxes	14,360	5,097	19,785	3,940
Income from continuing operations, net of tax	38,920	8,580	92,519	6,484
(Loss) income from discontinued operations, net of tax	(115)	(426)	(618)	540
Net income	38,805	8,154	91,901	7,024
Net income available to common stockholders	$ 35,346	$ 6,104	$ 34,563	$ 3,230
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ 2.53	$ 0.50	$ 2.63	$ 0.21
Discontinued operations (in dollars per share)	(0.01)	(0.03)	(0.05)	0.04
Basic earnings per common share (in dollars per share)	2.52	0.47	2.58	0.25
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	2.51	0.50	2.62	0.21
Discontinued operations (in dollars per share)	(0.01)	(0.03)	(0.05)	0.04
Diluted (loss) earnings per common share (in dollars per share)	$ 2.50	$ 0.47	$ 2.57	$ 0.25
Weighted-average number of common shares outstanding:
Basic (in shares)	14,026,039	12,993,934	13,367,605	12,956,222
Diluted (in shares)	14,133,904	13,004,449	13,415,344	12,977,598

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total		Preferred Stock Conversion Agreement	Common Stock	Common StockPreferred Stock Conversion Agreement	Additional Paid-in Capital	Additional Paid-in CapitalPreferred Stock Conversion Agreement	Retained Earnings	Retained EarningsPreferred Stock Conversion Agreement		Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2018					17,784,769							4,970,093
Beginning Balance at Dec. 31, 2018		$ 310,998			$ 18		$ 334,744		$ 187,127			$ (210,891)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		582							582
Stock-based compensation		2,103					2,103
Exercise of employee stock options (in shares)					57,022
Exercise of employee stock options		2,557			$ 0		2,557
Restricted stock issued (in shares)					25,357							3,459
Restricted stock issued		(217)										$ (217)
Shares issued for bonus settlement and director stipends (in shares)					599
Shares issued for bonus settlement and director stipends		0
Convertible preferred stock dividends	[1]	(1,087)							(1,087)
Ending Balance (in shares) at Mar. 31, 2019					17,867,747							4,973,552
Ending Balance at Mar. 31, 2019		314,936			$ 18		339,404		186,622			$ (211,108)
Beginning Balance (in shares) at Dec. 31, 2018					17,784,769							4,970,093
Beginning Balance at Dec. 31, 2018		310,998			$ 18		334,744		187,127			$ (210,891)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		7,024
Ending Balance (in shares) at Sep. 30, 2019					17,967,996							5,081,434
Ending Balance at Sep. 30, 2019		319,655			$ 18		346,034		190,857			$ (217,254)
Beginning Balance (in shares) at Mar. 31, 2019					17,867,747							4,973,552
Beginning Balance at Mar. 31, 2019		314,936			$ 18		339,404		186,622			$ (211,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(1,712)							(1,712)
Stock-based compensation		1,289					1,289
Exercise of employee stock options (in shares)					67,931
Exercise of employee stock options		3,826					3,826
Restricted stock issued (in shares)					7,088							2,419
Restricted stock issued		(155)										$ (155)
Shares issued for bonus settlement and director stipends (in shares)					202
Shares issued for bonus settlement and director stipends		0
Conversion of convertible preferred stock to common stock (in shares)					4,104
Conversion of convertible preferred stock to common stock		157					157
Convertible preferred stock dividends	[1]	(1,098)							(1,098)
Ending Balance (in shares) at Jun. 30, 2019					17,947,072							4,975,971
Ending Balance at Jun. 30, 2019		317,243			$ 18		344,676		183,812			$ (211,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		8,154							8,154
Stock-based compensation		855					855
Exercise of employee stock options (in shares)					17,755
Exercise of employee stock options		503					503
Restricted stock issued (in shares)					2,313							42
Restricted stock issued		(3)										$ (3)
Shares issued for bonus settlement and director stipends (in shares)					856
Shares issued for bonus settlement and director stipends		0
Stock repurchase plan (in shares)												105,421
Stock repurchase plan		(5,988)										$ (5,988)
Convertible preferred stock dividends	[1]	(1,109)							(1,109)
Ending Balance (in shares) at Sep. 30, 2019					17,967,996							5,081,434
Ending Balance at Sep. 30, 2019		319,655			$ 18		346,034		190,857			$ (217,254)
Beginning Balance (in shares) at Dec. 31, 2019					18,073,763							5,088,782
Beginning Balance at Dec. 31, 2019		317,592			$ 18		351,529		183,733			$ (217,688)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		16,098							16,098
Stock-based compensation		1,005					1,005
Exercise of employee stock options (in shares)					39,111
Exercise of employee stock options		2,054					2,054
Restricted stock issued (in shares)					79,029							626
Restricted stock issued		(37)										$ (37)
Shares issued for bonus settlement and director stipends (in shares)					701
Shares issued for bonus settlement and director stipends		38					38
Stock repurchase plan (in shares)												142,821
Stock repurchase plan		$ (7,299)										$ (7,299)
Conversion of convertible preferred stock to common stock (in shares)		40
Conversion of convertible preferred stock to common stock		$ 2					2
Convertible preferred stock dividends	[2],[3]	(1,095)							(1,095)
Ending Balance (in shares) at Mar. 31, 2020					18,192,644							5,232,229
Ending Balance at Mar. 31, 2020		328,358			$ 18		354,628		198,736			$ (225,024)
Beginning Balance (in shares) at Dec. 31, 2019					18,073,763							5,088,782
Beginning Balance at Dec. 31, 2019		317,592			$ 18		351,529		183,733			$ (217,688)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		91,901
Ending Balance (in shares) at Sep. 30, 2020					19,468,591							5,285,666
Ending Balance at Sep. 30, 2020		410,067			$ 20		416,504		221,509			$ (227,966)
Beginning Balance (in shares) at Mar. 31, 2020					18,192,644							5,232,229
Beginning Balance at Mar. 31, 2020		328,358			$ 18		354,628		198,736			$ (225,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		36,998							36,998
Stock-based compensation		691					691
Exercise of employee stock options (in shares)					129,722
Exercise of employee stock options		9,275					9,275
Restricted stock forfeited (in shares)					(8,496)
Shares issued for bonus settlement and director stipends (in shares)					487
Shares issued for bonus settlement and director stipends		38					38
Stock repurchase plan (in shares)												52,856
Stock repurchase plan		(2,887)										$ (2,887)
Conversion of convertible preferred stock to common stock (in shares)					14,166	925,567
Conversion of convertible preferred stock to common stock		546		$ 31,259		$ 1	546	$ 37,255		$ (5,997)
Redemption of convertible preferred stock pursuant to Conversion Agreement				(42,954)						(42,954)
Convertible preferred stock dividends	[2]	(866)	[3]						(866)
Ending Balance (in shares) at Jun. 30, 2020					19,254,090							5,285,085
Ending Balance at Jun. 30, 2020		360,458			$ 19		402,433		185,917			$ (227,911)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		38,805							38,805
Stock-based compensation		1,139					1,139
Exercise of employee stock options (in shares)					145,124
Exercise of employee stock options		10,251			$ 1		10,250
Restricted stock issued (in shares)					330							581
Restricted stock issued		(55)										$ (55)
Shares issued for bonus settlement and director stipends (in shares)					414
Shares issued for bonus settlement and director stipends		38					38
Conversion of convertible preferred stock to common stock (in shares)					68,633
Conversion of convertible preferred stock to common stock		2,644					2,644
Redemption of convertible preferred stock pursuant to Conversion Agreement				(3,186)						(3,186)
Dividends paid pursuant to the Conversion Agreement	[4]			$ (27)						$ (27)	[3]
Ending Balance (in shares) at Sep. 30, 2020					19,468,591							5,285,666
Ending Balance at Sep. 30, 2020		$ 410,067			$ 20		$ 416,504		$ 221,509			$ (227,966)
[1]	Cash dividends on redeemable convertible preferred stock of $1.36, $1.37, and $1.38 per share were distributed to convertible preferred stockholders for the three months ended March 31, 2019, June 30, 2019, and September 30, 2019, respectively.
[2]	Cash dividends on redeemable convertible preferred stock of $1.37 per share were distributed to convertible preferred stockholders for the three months ended March 31, 2020 and June 30, 2020.
[3]	Cash dividends on redeemable convertible preferred stock of $1.37 per share were distributed to convertible preferred stockholders for the three months ended March 31, 2020 and June 30, 2020. (2) On September 3, 2020, accrued cash dividends of $1.37 per share were paid to Coliseum Capital Partners, L.P. and certain funds and accounts managed by Coliseum Capital Management, LLC pursuant to the Preferred Stock Conversion Agreement as discussed in Note 10, Stock-Based Compensation and Similar Arrangements.
[4]	On September 3, 2020, accrued cash dividends of $1.37 per share were paid to Coliseum Capital Partners, L.P. and certain funds and accounts managed by Coliseum Capital Management, LLC pursuant to the Preferred Stock Conversion Agreement as discussed in Note 10, Stock-Based Compensation and Similar Arrangements.

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Preferred stock, dividends per share (in USD per share)	$ 1.37	$ 1.37	$ 1.37	$ 1.38	$ 1.37	$ 1.36

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities
Net income	$ 91,901	$ 7,024
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	6,980	8,300
Amortization	10,219	4,676
Provision for doubtful accounts	(3,139)	533
Stock-based compensation	2,949	4,247
Deferred income taxes	12,612	1,993
Amortization of deferred financing costs and debt discount	292	272
Equity in net (income) loss of investee	(12,200)	6,159
Reduction of right of use assets	6,769	7,668
Changes in operating assets and liabilities:
Accounts receivable and other receivables	20,017	(44,374)
Prepaid expenses and other	(28,216)	(8,779)
Income tax refunds on sale of business	17,789	37,271
Self-funded insurance programs	1,259	2,511
Accounts payable and accrued expenses	121,408	(9,384)
Accrued transportation costs	(5,506)	27,522
Deferred revenue	453	(486)
Long-term contract payables and other long-term liabilities	43,639	(5,084)
Net cash provided by operating activities	287,226	40,069
Investing activities
Purchase of property and equipment	(4,786)	(7,302)
Acquisition, net of cash acquired	(77,665)	0
Net cash used in investing activities	(82,451)	(7,302)
Financing activities
Proceeds from debt	162,000	12,000
Repayment of debt	(162,000)	(12,000)
Preferred stock redemption payment	(88,743)	0
Preferred stock dividends	(1,988)	(3,295)
Repurchase of common stock, for treasury	(10,186)	(6,363)
Proceeds from common stock issued pursuant to stock option exercise	21,581	6,885
Restricted stock surrendered for employee tax payment	(92)	0
Other financing activities	(204)	(641)
Net cash used in financing activities	(79,632)	(3,414)
Net change in cash, cash equivalents and restricted cash	125,143	29,353
Cash, cash equivalents and restricted cash at beginning of period	61,673	12,367
Cash, cash equivalents and restricted cash at end of period	$ 186,816	$ 41,720

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Statement of Cash Flows [Abstract]
Cash paid for interest	$ 1,775	$ 1,090
Cash paid (received) for income taxes, net of refunds	11,805	(30,456)
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 5,488	$ 4,770

Organization and Basis of Prese

Organization and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Description of Business The Providence Service Corporation (“we”, the “Company” or “Providence”) is the largest benefits manager of non-emergency medical transportation (“NEMT” or "NET") programs for state governments and managed care organizations (“MCOs”) in the United States (“U.S.”) through the wholly-owned subsidiary, LogistiCare Solutions, LLC, a Delaware limited liability company and the brands “LogistiCare” and “Circulation”. The technology-enabled operating model includes core competencies in risk underwriting, call center management, network credentialing, vendor payment management and non-emergency medical transport management. Through this model, the Company provides a suite of integrated supportive care solutions for our payor customers and end-users, focused on addressing the social determinates of health (“SDoH”) and enabling greater access to healthcare and improved outcomes. The Company also own a 43.6% minority investment in CCHN Group Holdings, Inc. and its subsidiaries (“Matrix”). Matrix is a nationwide provider of a broad array of assessment and care management services that improve health outcomes for individuals and financial performance for health plans. Matrix’s national network of community-based clinicians delivers in-home and on-site services while its fleet of mobile health clinics provides community-based care with advanced diagnostic capabilities. In 2020, Matrix launched its Employee Health and Wellness solution focused on improving employee health with worksite solutions that reinforce business resilience and safe return-to-work outcomes. These solutions combined with Matrix’s advanced engagement approach, help health plans manage risks, close care gaps and connect members to care. In 2018, the Company acquired Circulation to provide additional technological improvements through their digital transportation platform. Circulation’s technology allows for real time notifications to members on their mobile devices, integration with a wide variety of ATMS and transportation network companies, real time ride tracking, network management and analytics. During 2019, the Company consolidated all activities and functions performed at the corporate holding company level into its NET Services segment (“Organizational Consolidation”). As a result of the Organizational Consolidation, the Company incurred restructuring and related organization costs. See Note 8, Restructuring and Related Reorganization Costs, for further information. On May 6, 2020, LogistiCare entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Specialty Benefits, LLC., a Delaware corporation (the “Seller”), National MedTrans, LLC, a New York limited liability company (“NMT”) and for limited purposes therein, United Healthcare Services, Inc., a Minnesota corporation. NMT services contractual relationships to provide non-emergency medical transportation. Pursuant to the terms of the Purchase Agreement, LogistiCare acquired all of the outstanding capital stock of NMT. See Note 15, Acquisitions, for further information. Basis of Presentation The Company follows accounting standards set by the Financial Accounting Standards Board (“FASB”). The FASB establishes accounting principles generally accepted in the United States (“GAAP”). Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. References to GAAP issued by the FASB in these footnotes are to the FASB Accounting Standards Codification (“ASC”), which serves as the single source of authoritative accounting and applicable reporting standards to be applied for non-governmental entities. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for the fair presentation of the results of the interim periods have been included. The Company has made estimates relating to the reporting of assets and liabilities, revenues and expenses and certain disclosures in the preparation of these unaudited condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020. Management has evaluated events and transactions that occurred after the balance sheet date and through the date these unaudited condensed consolidated financial statements were filed with the SEC and considered the effect of such events in the preparation of these condensed consolidated financial statements. The condensed consolidated balance sheet at December 31, 2019 included in this Form 10-Q has been derived from audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements contained herein should be read in conjunction with the audited financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The Company accounts for its investment in Matrix using the equity method, as the Company does not control the decision-making process or business management practices of Matrix. While the Company has access to certain information and performs certain procedures to review the reasonableness of information, the Company relies on the management of Matrix to provide accurate financial information prepared in accordance with GAAP. The Company receives audit reports relating to such financial information from Matrix’s independent auditors on an annual basis. The Company is not aware of any errors in or possible misstatements of the financial information provided by Matrix that would have a material effect on the Company’s condensed consolidated financial statements. See Note 5, Equity Investment , for further information. Uncertainties due to COVID-19 In December 2019, an outbreak of a new strain of a coronavirus causing a coronavirus disease ("COVID-19"), began in Wuhan, Hubei Province, China. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. COVID-19, as well as measures taken by governmental authorities and private actors to limit the spread of this virus, has and is likely to continue to interfere with the ability of the Company's employees, suppliers, transportation providers and other business providers to carry out their assigned tasks at ordinary levels of performance relative to the conduct of the Company’s business which may cause the Company to materially curtail certain business operations. While the Company is monitoring the impact of COVID-19 on its business and financial results, at this time the Company is unable to accurately predict the extent to which the COVID-19 pandemic impacts its business, operations and financial results. On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which includes modifications to the limitation on business interest expense and net operating loss provisions, and provides a delay in the payment of employer federal payroll taxes during 2020 after the date of enactment. Due to the favorable impact of the CARES Act on the Company’s 2018 U.S. net operating losses ("NOLs"), the effective tax rate of 17.6% was lower than the U.S. federal statutory rate of 21.0% for the nine months ended September 30, 2020. The 27.0% effective tax rate for the three months ended September 30, 2020 was not impacted by the CARES Act. See Note 12, Income Taxes , for further information. The accompanying unaudited condensed consolidated financial statements reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and reported amounts of revenue and expenses. It is possible that the Company's assumptions and estimates may materially change due to these uncertainties. Reclassifications During the nine months ended September 30, 2020, the Company has separately classified the reduction of right-of-use assets in its unaudited condensed consolidated statement of cash flows and conformed the prior period.

Significant Accounting Policies

Significant Accounting Policies and Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Significant Accounting Policies and Recent Accounting Pronouncements	Significant Accounting Policies and Recent Accounting Pronouncements The Company adopted the following accounting pronouncements during the nine months ended September 30, 2020: In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”). The amendments in ASU 2016-13 superseded much of the existing guidance for reporting credit losses for assets held at amortized cost basis and available for sale debt securities. The amendments in ASU 2016-13 affected loans, debt securities, trade receivables, net investments in leases, off-balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The Company adopted ASU 2016-13 on January 1, 2020. As of September 30, 2020, this guidance did not have a material impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”) which removed, modified, and added additional disclosures related to fair value measurements. The Company adopted ASU 2018-13 on January 1, 2020. As of September 30, 2020, this guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (“ASU 2018-15”). ASU 2018-15 aligned the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company elected to apply the prospective transition approach and therefore applied the transition requirements to any eligible costs incurred after adoption. The Company adopted ASU 2018-15 on January 1, 2020. As of September 30, 2020, the Company has not incurred any material implementation costs associated with new service contracts since the date of adoption. In February 2020, the FASB issued ASU No. 2020-02, Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) ("ASU 2020-02"). ASU 2020-02 provides interpretive guidance on methodologies and supporting documentation for measuring credit losses, with a focus on the documentation the SEC would normally expect registrants engaged in lending transactions to prepare and maintain to support estimates of current expected credit losses for loan transactions. The Company adopted ASU 2020-02 on February 6, 2020, as the ASU was effective upon issuance. As of September 30, 2020, this guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments ("ASU 2020-03") to make improvements to ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") . Public business entities that meet the definition of an SEC filer, excluding eligible smaller reporting companies as defined by the SEC, should adopt ASU 2020-03 during 2020. The Company adopted ASU 2020-03 on April 1, 2020. This guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. Recent accounting pronouncements that the Company has yet to adopt are as follows: In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). The ASU removes certain exceptions to the general principles in ASC 740, Income Taxes , and also clarifies and amends existing guidance to improve consistent application. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company is currently evaluating the impact of this ASU, but does not expect a material impact to the financial statements upon adoption. In January 2020, the FASB issued ASU 2020-01, Clarifying the Interactions Between Topic 321, Topic 323, and Topic 81 5 ("ASU 2020-01"), to clarify the interaction among the accounting standards for equity securities, equity method investments and certain derivatives. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the impact ASU 2020-01 will have on its consolidated financial statements or disclosures; however, does not expect the adoption to have a material impact. In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04") which provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships, and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discontinued due to reference rate reform. The relief granted in ASC 848, Reference Rate Reform ("ASC 848"), is applicable only to legacy contracts if the amendments made to the agreements are solely for reference rate reform activities. The provisions of ASC 848 must be applied for all transactions other than derivatives, which may be applied at a hedging relationship level. Entities may apply the provisions as of the beginning of the reporting period when the election is made (i.e. as early as the first quarter 2020). Unlike other topics, the provisions of this update are only available until December 31, 2022, when the reference rate replacement activity is expected to be completed. The Company is currently evaluating the impact ASU 2020-04 will have on its consolidated financial statements or disclosures; however, does not expect the adoption to have a material impact. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06") which addresses the complexity associated with applying generally accepted accounting principles (GAAP) for certain financial instruments with characteristics of liabilities and equity. The update limits the accounting models for convertible instruments resulting in fewer embedded conversion features being separately recognized from the host contract. Specifically, ASU 2020-06 removes from GAAP the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. ASU 2020-06 is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods therein. The Company is currently evaluating the impact ASU 2020-06 will have on its consolidated financial statements or disclosures.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table summarizes disaggregated revenue from contracts with customers by contract type (in thousands): Three months ended September 30, 2020 2019 State Medicaid agency contracts $ 154,689 $ 196,891 Managed care organization contracts 165,930 196,494 Total Service revenue, net $ 320,619 $ 393,385 Capitated contracts $ 277,908 $ 334,549 Non-capitated contracts 42,711 58,836 Total Service revenue, net $ 320,619 $ 393,385 Nine months ended September 30, 2020 2019 State Medicaid agency contracts $ 486,964 $ 551,632 Managed care organization contracts 483,202 573,479 Total Service revenue, net $ 970,166 $ 1,125,111 Capitated contracts $ 832,490 $ 947,811 Non-capitated contracts 137,676 177,300 Total Service revenue, net $ 970,166 $ 1,125,111 During the three months ended September 30, 2020 and 2019, the Company recognized $0.6 million and $15.3 million of service revenue respectively, from adjustments relating to performance obligations satisfied in previous periods to which the customer agreed. During the nine months ended September 30, 2020 and 2019, the Company recogniz e d $0.4 million and $8.5 million, of service revenue respectively, from contractual adjustments relating to performance obligations satisfied in previous periods to which the customer agreed. Related Balance Sheet Accounts The following table provides information about accounts receivable, net (in thousands): September 30, 2020 December 31, 2019 Accounts receivable $ 118,101 $ 124,868 Reconciliation contracts receivable 49,637 61,481 Allowance for doubtful accounts (2,794) (5,933) Accounts receivable, net $ 164,944 $ 180,416 The following table provides information about other accounts included on the accompanying condensed consolidated balance sheets (in thousands): September 30, 2020 December 31, 2019 Accrued contract payables, current, included in “Accrued expenses” (1) $ 88,347 $ 15,706 Long-term contract payables (2) 50,244 — Deferred revenue, current 681 227 Deferred revenue, long-term, included in “Other long-term liabilities” 629 758 During the nine months ended September 30, 2020 and 2019, the Company recognized $0.2 million and $0.4 million of deferred revenue, respectively. (1) Accrued contract payables, current, primarily represents overpayments and liability reserves on certain profit corridor and reconciliation contracts due to lower activity as a result of COVID-19. (2) Long-term contract payables primarily represents liability reserves on certain profit corridor and reconciliation contracts due to lower activity as a result of COVID-19 that may be repaid in greater than 12 months.

Cash, Cash Equivalents and Rest

Cash, Cash Equivalents and Restricted Cash	9 Months Ended
	Sep. 30, 2020
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2020 2019 Cash and cash equivalents $ 183,277 $ 40,637 Restricted cash, current 3,182 833 Current assets of discontinued operations 357 250 Cash, cash equivalents and restricted cash $ 186,816 $ 41,720 Restricted cash as of September 30, 2020 relates to a security reserve obtained as part of the NMT acquisition. Restricted cash as of September 30, 2019 primarily relates to amounts held in trusts for reinsurance claims losses under the Company’s now dissolved captive insurance operation for historical workers’ compensation, general and professional liability and auto liability reinsurance programs, as well as amounts restricted for withdrawal under our self-insured medical and benefits plans. See Note 15, Acquisition , for further information on the security reserve. The wholly-owned captive insurance subsidiary, Social Services Providers Captive Insurance Company ("SPCIC"), was dissolved during the nine months ended September 30, 2020. Current assets of discontinued operations principally reflect the cash position of WD Services operations in Saudi Arabia, which the Company is winding down. See Note 16, Discontinued Operations

Equity Investment

Equity Investment	9 Months Ended
	Sep. 30, 2020
Equity Method Investment, Summarized Financial Information [Abstract]
Equity Investment	Equity Investment As of September 30, 2020 and December 31, 2019, the Company owned a 43.6% non-controlling interest in Matrix. Affiliates of Frazier Healthcare Partners hold rights necessary to control the fundamental operations of Matrix. The Company accounts for this investment in Matrix under the equity method of accounting. The Company’s share of Matrix’s income or losses are recorded as “Equity in net (income) loss of investee” in the accompanying unaudited condensed consolidated statements of operations and the investment basis is recorded as "Equity investment" in the accompanying condensed consolidated balance sheets. During the fourth quarter of the year ended December 31, 2019, Matrix recorded asset impairment charges of $55.1 million. No impairment was recorded during the nine months ended September 30, 2020 or 2019. The carrying amount of the assets included in the Company’s condensed consolidated balance sheets and the maximum loss exposure related to the Company’s interest in Matrix as of September 30, 2020 and December 31, 2019 totaled $141.3 million and $130.9 million , respectively. Summary financial information for Matrix on a standalone basis is as follows (in thousands): September 30, 2020 December 31, 2019 Current assets $ 149,548 $ 64,221 Long-term assets 618,905 631,007 Current liabilities 65,808 31,256 Long-term liabilities 364,061 351,380 Three months ended September 30, 2020 2019 Revenue $ 140,728 $ 71,663 Operating income (loss) 35,489 (2,640) Net income (loss) 21,382 (6,906) Nine months ended September 30, 2020 2019 Revenue $ 292,699 $ 210,807 Operating income (loss) 49,074 (542) Net income (loss) 23,917 (15,054)

Prepaid Expenses and Other

Prepaid Expenses and Other	9 Months Ended
	Sep. 30, 2020
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid Expenses and Other	Prepaid Expenses and Other Prepaid expenses and other were comprised of the following (in thousands): September 30, 2020 December 31, 2019 Prepaid income taxes $ 8,105 $ 2,942 Prepaid insurance 3,277 1,317 Prepaid rent 849 868 Other prepaid expenses 8,035 5,815 Total prepaid expenses and other $ 20,266 $ 10,942

Accrued Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2020
Accrued Liabilities, Current [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consisted of the following (in thousands): September 30, 2020 December 31, 2019 Accrued compensation and related liabilities $ 28,470 $ 8,941 Accrued contract payables, current 88,347 15,706 Accrued cash settled stock-based compensation 10,021 3,282 Other accrued expenses 16,195 10,804 Total accrued expenses $ 143,033 $ 38,733

Restructuring and Related Reorg

Restructuring and Related Reorganization Costs	9 Months Ended
	Sep. 30, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Organization Costs	Restructuring and Related Reorganization Costs The Company completed an Organizational Consolidation in 2019 during which it closed the corporate offices in Stamford, Connecticut and Tucson, Arizona. A total of $0.6 million and $3.7 million in restructuring and related costs was incurred during the three and nine months ended September 30, 2019, respectively, related to the Organizational Consolidation. These costs include, respectively, $0.1 million and $2.4 million of retention and personnel costs, $0.0 million and $0.3 million of stock-based compensation expense, $0.0 million and $0.2 million of depreciation and $0.5 million and $0.8 million of other costs, primarily related to recruiting and legal costs. These costs are recorded as “General and administrative expense” and “Depreciation and amortization” in the accompanying condensed consolidated statements of operations. A t otal of $13.1 million in restructuring and related costs was incurred on a cumulative basis through December 31, 2019 related to the Organizational Consolidation. These costs include $7.5 million of retention and personnel costs, $2.0 million of stock-based compensation expense, $0.7 million of depreciation and $2.8 million of other costs, primarily related to recruiting and legal costs. The summary of the liability for restructuring and related reorganization costs is as follows (in thousands): As of January 1, 2019 Costs Cash Payments As of December 31, 2019 Retention and personnel liability $ 1,956 $ 2,418 $ (4,374) $ — Other liability 398 1,308 (1,706) — Total $ 2,354 $ 3,726 $ (6,080) $ — No restructuring or related costs were incurred related to the Organizational Consolidation during the three and nine months ended September 30, 2020. There was no restructuring liability as of September 30, 2020. During the nine months ended September 30, 2020, the Company incurred approximately $0.7 million of restructuring expense for the closure of its Las Vegas contact center. The majority of these costs were recorded to “Service expense” and the remainder were recorded to "General and administrative expense".

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt	Debt The Company is a party to the amended and restated credit and guaranty agreement, dated as of August 2, 2013 (as amended, the “Credit Agreement”), with Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer, and the other lenders party thereto. On May 6, 2020, the Company entered into the Seventh Amendment to the Amended and Restated Credit and Guaranty Agreement (the “Seventh Amendment”) which, among other things, extended the maturity date to August 1, 2021, expanded the amount available under the revolving credit facility (the “Credit Facility”) from $200.0 million to $225.0 million, and increased the sub-facility for letters of credits from $25.0 million to $40.0 million. Interest on the loans is payable quarterly in arrears. In addition, the Company is obligated to pay a quarterly commitment fee based on a percentage of the unused portion of each lender’s commitment under the Credit Facility and quarterly letter of credit fees based on a percentage of the maximum amount available to be drawn under each outstanding letter of credit. As of September 30, 2020, the Company had no borrowings outstanding on the Credit Facility; however, had letters of credit outstanding in the amount of $16.9 million. The Company’s available credit under the Credit Facility was $208.1 million. Under the Credit Agreement, the Company has an option to request an increase in the amount of the revolving credit facility from time to time (on substantially the same terms as apply to the existing facilities) in an aggregate amount of up to $75.0 million with either additional commitments from lenders under the Credit Agreement at such time or new commitments from financial institutions acceptable to the administrative agent in its reasonable discretion, so long as no default or event of default exists at the time of any such increase. The Company may not be able to access additional funds under this increase option as no lender is obligated to participate in any such increase under the Credit Facility. On October 16, 2020, the Company entered into the Eighth Amendment to the Amended and Restated Credit and Guaranty Agreement (the “Eighth Amendment”), which among other things, amended the Credit Facility to permit the incurrence of additional debt to finance the acquisition (the "Simplura Acquisition") of OEP AM, Inc., a Delaware corporation, doing business as Simplura Health Group (“Simplura” and, together with its subsidiaries, the “Simplura Group”), permit borrowing under the Credit Facility to partially fund the Simplura Acquisition with limited conditions to such borrowing, increase the top interest rate margin that may apply to loans thereunder, and revise our permitted ratio of EBITDA to indebtedness. In addition, the Eighth Amendment extended the maturity date to August 2, 2023. See Note 18, Subsequent Events , for further information on the acquisition.

Stock-Based Compensation and Si

Stock-Based Compensation and Similar Arrangements	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation and Similar Arrangements	Stock-Based Compensation and Similar ArrangementsThe Company provides stock-based compensation to employees and non-employee directors under the Company’s 2006 Long-Term Incentive Plan (“2006 Plan”). The 2006 Plan allows the flexibility to grant or award stock options, stock appreciation rights, restricted stock, unrestricted stock, stock units including restricted stock units and performance awards to eligible persons. The following table reflects the amount of stock-based compensation, for share settled grants or awards, recorded in each financial statement line item for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Service expense $ 55 $ 162 $ 174 $ 488 General and administrative expense 1,122 693 2,775 3,759 Total stock-based compensation $ 1,177 $ 855 $ 2,949 $ 4,247 At September 30, 2020, the Company had 358,953 stock options outstanding with a weighted-average exercise price of $63.02. T he Company also had 55,469 unvested restricted stock awards ("RSAs") and 46,021 unvested restricted stock units ("RSUs") outstanding at September 30, 2020 with a weighted-average grant date fair value of $62.78 and $63.17 , re spectively. Cash-Settled Awards The Company also grants stock equivalent unit awards (“SEUs”) and stock option equivalent units that are cash-settled awards and are not included as part of the 2006 Plan. During the three months ended September 30, 2020 and 2019, the Company r ecorded expense of $2.9 million a nd $0.4 million for cash-settled awards, respectively. During the nine months ended September 30, 2020 and 2019, the Company r ecorded expense of $6.9 million a nd income of $0.2 million for cash-settled awards, respectively. The expense and benefit for cash-settled awards is included as “General and administrative expense” in the accompanying condensed consolidated statements of operations. As the instruments are accounted for as liability awards, the income or expense recorded for the three and nine months ended September 30, 2020 and 2019 are attributable to the Company’s change in stock price from the previous reporting peri od. The liability for unexercised cash-settled share-based payment awards of $10.0 million a nd $3.3 million at September 30, 2020 and December 31, 2019, respectively, is reflected in “Accrued expenses” in the condensed consolidated balance sheets. At September 30, 2020, the Company had 3,862 SEUs and 200,000 s tock option equivalent units outstanding. Long-Term Incentive Plans In connection with the acquisition of Circulation during 2018, the Company established a management incentive plan (“MIP”) intended to motivate key employees of Circulation. During the three months ended March 31, 2019, the MIP was amended to remove the previously included performance requirements and to provide for a total fixed payment of $12.0 million to the group of MIP participants. During the year ended December 31, 2019, the MIP was further amended to a total fixed payment of $2.7 million. The payout date is within 30 days following the finalization of the Company’s audited financial statements for the fiscal year ending December 31, 2021 and is subject to the participant remaining employed by the Company through December 31, 2021, except for certain termination scenarios. As of September 30, 2020 and December 31, 2019, the Company has accrued $1.8 million and $1.1 million, respectively, related to the MIP, which is primarily reflected in “Other long-term liabilities” in the condensed consolidated balance sheets. Preferred Stock Conversion On June 8, 2020, the Company entered into a Preferred Stock Conversion Agreement (the “Conversion Agreement”) with Coliseum Capital Partners, L.P. and certain funds and accounts managed by Coliseum Capital Management, LLC (collectively, the “Holders”), pursuant to which, among other things, (a) the Company agreed to purchase 369,120 shares of Series A Convertible Preferred Stock, par value $0.001 per share, held by the Holders in the aggregate, in exchange for (i) $209.88 in cash per share of Series A Preferred Stock, plus (ii) a cash amount equal to accrued but unpaid dividends on such shares of Series A Preferred Stock through the day prior to June 11, 2020, and (b) the Holders converted 369,120 shares of Series A Preferred Stock into (i) 2.5075 shares of Common Stock of the Company for each share of Series A Preferred Stock, plus (ii) a cash payment equal to accrued but unpaid dividends on such shares of Series A Preferred Stock through the day prior to June 11, 2020, plus (iii) a cash payment of $8.82 per share of Series A Preferred Stock. The Conversion Agreement was considered to be an induced conversion in which a premium consideration was provided by the Company to Holders of the Series A Preferred Stock. On September 3, 2020, the Company elected to effect the conversion (the “Conversion”) of all of the outstanding Series A Convertible Preferred Stock. In accordance with the Preferred Stock Conversion Agreement dated June 8, 2020, the Company repurchased 27,509 shares of Series A Preferred Stock from the Holders for (i) a cash amount equal to $209.88 per share of Series A Preferred Stock, plus (ii) a cash amount equal to accrued but unpaid dividends on such shares through the day prior to the Conversion. In connection with the Conversion, all remaining outstanding shares of Series A Preferred Stock were converted into Common Stock at the conversion rate of 2.5075 shares of Common Stock for each share of Series A Preferred Stock and cash-in-lieu of fractional shares. The following table summarizes the convertible preferred stock activity in 2020 (in thousands, except share count): Dollar Value Share Count Balance at January 1, 2020 $ 77,120 798,788 Conversion to common stock (572) (5,666) Conversion to common stock pursuant to Conversion Agreement (37,256) (369,120) Preferred stock redemption pursuant to Conversion Agreement (37,256) (369,120) Reduction of unamortized issuance cost 3,263 — Balance at June 30, 2020 $ 5,299 54,882 Conversion to common stock (2,763) (27,373) Preferred stock redemption pursuant to Conversion Agreement (2,777) (27,509) Reduction of unamortized issuance cost 241 — Balance at September 30, 2020 $ — — In accordance with ASC 260 Earnings Per Share, retained earnings was reduced by the excess of the fair value of the consideration transferred over the carrying amount of the shares surrendered. The impact to retained earnings of the excess consideration transferred, including the direct costs incurred, and write-off of any unamortized issuance costs was $52.1 million as of September 30, 2020. As of September 30, 2020, there were no outstanding shares of convertible preferred stock.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table details the computation of basic and diluted earnings per share (in thousands, except share and per share data): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Numerator: Net income $ 38,805 $ 8,154 $ 91,901 $ 7,024 Dividends on convertible preferred stock outstanding — (1,109) (1,171) (3,295) Dividends paid pursuant to the Conversion Agreement (27) — (817) — Consideration paid in excess of preferred cost basis pursuant to the Conversion Agreement (3,186) — (52,137) — Income allocated to participating securities (246) (941) (3,213) (499) Net income available to common stockholders $ 35,346 $ 6,104 $ 34,563 $ 3,230 Continuing operations $ 35,461 $ 6,473 $ 35,181 $ 2,762 Discontinued operations (115) (369) (618) 468 Net income available to common stockholders $ 35,346 $ 6,104 $ 34,563 $ 3,230 Denominator: Denominator for basic earnings per share -- weighted-average shares 14,026,039 12,993,934 13,367,605 12,956,222 Effect of dilutive securities: Common stock options 61,312 10,515 15,730 21,376 Restricted stock 46,553 — 32,009 — Denominator for diluted earnings per share -- adjusted weighted-average shares assumed conversion 14,133,904 13,004,449 13,415,344 12,977,598 Basic earnings (loss) per share: Continuing operations $ 2.53 $ 0.50 $ 2.63 $ 0.21 Discontinued operations (0.01) (0.03) (0.05) 0.04 Basic earnings per share $ 2.52 $ 0.47 $ 2.58 $ 0.25 Diluted earnings (loss) per share: Continuing operations $ 2.51 $ 0.50 $ 2.62 $ 0.21 Discontinued operations (0.01) (0.03) (0.05) 0.04 Diluted earnings per share $ 2.50 $ 0.47 $ 2.57 $ 0.25 Income allocated to participating securities is calculated by allocating a portion of net income attributable to Providence, less dividends on convertible stock, to the convertible preferred stockholders on a pro-rata, as converted basis; however, the convertible preferred stockholders are not allocated losses. In accordance with ASC 260, Earnings Per Share , and as related to the Conversion Agreement discussed in Note 10, Stock-Based Compensation and Similar Arrangements, the numerator was adjusted by the excess of the fair value of consideration paid over the carrying amount of the shares surrendered, net of issuance costs. The following weighted-average shares were not included in the computation of diluted earnings per share as the effect of their inclusion would have been anti-dilutive: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Stock options to purchase common stock 3,481 420,846 170,076 499,611 Convertible preferred stock 38,851 799,969 487,576 800,983

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rate for continuing operations for the three and nine months ended September 30, 2020 was 27.0% and 17.6%, respectively. The effective tax rate for continuing operations for the three and nine months ended September 30, 2019 was 37.3% and 37.8%, respectively. For the nine months ended September 30, 2020, the effective tax rate was lower than the U.S. federal statutory rate of 21.0% primarily due to the favorable impact of the CARES Act on the Company’s 2018 U.S. net operating losses ("NOLs"). For the nine months ended September 30, 2019, t he effective tax rate was higher th an the U.S. federal statutory rate of 21.0% primarily due to state income taxes and certain non-deductible expenses. During 2019, the Company received refunds from the Internal Revenue Service (“IRS”) totaling $30.8 million resulting from the loss on the 2018 workforce development segment sale. As a result of the size of the refunds received, in October 2019, the IRS commenced a mandatory review by a joint committee of Congress. The review is still ongoing. The 2017 Tax Reform Act reduced the U.S. corporate income tax rate from 35% to 21% and provided that U.S. NOLs incurred after 2017 could only be carried forward to offset future taxable income. Pursuant to the CARES Act, which was enacted on March 27, 2020, the Company carried its 2018 NOL back five years. As a result, during the nine months ended September 30, 2020, the Company recorded a $27.3 million receivable for the 2018 U.S. NOL carryback, and a $11.0 million tax benefit from the favorable carryback tax rate of 35% compared to a carryforward tax rate of 21%. The Company also recorded an additional income tax payable of $3.5 million for 2019 as a result of the 2018 NOL being carried back instead of carried forward. As of September 30, 2020, the Company has received $17.0 million of the $27.3 million receivable for the 2018 U.S. NOL carryback. It is anticipated that the remaining $10.3 million refund will be received by year end. This $27.3 million is also subject to the ongoing IRS mandatory review. As discussed in Note 16, Discontinued Operations , the Company transferred its operations in Saudi Arabia to its contractual counterparties on January 1, 2019. In connection with the dissolution of its Saudi Arabia legal entity, the Company is protesting withholding tax and income tax assessments for the years 2012 through 2017. The Company does not believe the ultimate determination of the assessments will have a material adverse effect on its financial condition or results of discontinued operations.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal proceedings In the ordinary course of business, the Company is a party to various lawsuits. Management does not expect these lawsuits to have a material impact on the liquidity, results of operations, or financial condition of the Company. On January 21, 2019, the United States District Court for the Southern District of Ohio unsealed a qui tam complaint, filed in December 2015, against Mobile Care Group, Inc., Mobile Care Group of Ohio, LLC, Mobile Care EMS & Transport, Inc. and LogistiCare by Brandee White, Laura Cunningham, and Jeffery Wisier (the “Relators”) alleging violations of the federal False Claims Act by presenting claims for payment to government healthcare programs knowing that the prerequisites for such claims to be paid had not been met. The Relators seek to recover damages, fees and costs under the federal False Claims Act including treble damages, civil penalties and attorneys’ fees. In addition, the Relators seek reinstatement to their jobs with the Mobile Care entities. None of the Relators were employed by LogistiCare. Prior to January 21, 2019, LogistiCare had no knowledge of the complaint. The federal government has declined to intervene against LogistiCare. The Company filed a motion to dismiss the Complaint on April 22, 201 9. Although the outcome of such matter is inherently uncertain and may be materially adverse, based on current information, the Company does not expect the case to have a material adverse effect on our business, financial condition or results of operations. On April 1, 2019, a purported class action was filed against LogistiCare in Texas alleging that the Company’s policy with respect to timekeeping for hourly employees constituted violations of the federal Fair Labor Standards Act (“FLSA”), as well as wage and hour laws in South Carolina and Texas. Plaintiffs filed a motion for conditional certification on a nationwide basis, which LogistiCare contested. The court granted the conditional certification motion on January 22, 2020 and the Company filed an appeal of the conditional certification order. If this case goes forward as either a class action or individual claims, the Company plans to vigorously contest the allegations on the merits as the plaintiffs have mischaracterized the method by which employees clock into work. At this stage of the litigation, it is impossible to predict with any certainty whether plaintiffs will prevail on their claims, or what they might recover. On June 10, 2020, Gateway Insurance Company (“Gateway”), doing business in California as Alano Insurance Company, a subsidiary of Atlas Financial Holdings, Inc., entered liquidation. On August 11, 2020, American Service Insurance Company and American Country Insurance Company, subsidiaries of Atlas Financial, also entered liquidation. Gateway, American Service and American Country previously insured many of LogistiCare’s subcontracted transportation providers. LogistiCare is listed as an additional insured on these policies. LogistiCare currently has 26 active lawsuits involving Gateway, American Country Insurance Company and American Service Insurance Company. As a result of the liquidation, these suits will now be taken over by the state guaranty fund in which the suit is pending. LogistiCare will likely lose its additional insured status and be required to defend itself under its own insurance policies, which involve a self-insured retention. All of the lawsuits are currently stayed for a time period varying by state in order for the guaranty fund to take over the case. The Company has accrued reserves related to these lawsuits in accordance with ASC 450, Contingencies. Indemnifications The Company provided certain standard indemnifications in connection with the sale of the Human Services segment to Molina Healthcare Inc. (“Molina”) effective November 1, 2015. Certain representations made by the Company in the related Membership Interest Purchase Agreement (the “Molina Purchase Agreement”) including tax representations, survive until the expiration of applicable statutes of limitation. Molina and the Company entered into a settlement agreement regarding indemnification claims by Molina with respect to Rodriguez v. Providence Community Corrections (the “Rodriguez Litigation”), a complaint filed in the District Court for the Middle District of Tennessee, Nashville Division, against Providence Community Corrections, Inc. (“PCC”), an entity sold under the Molina Purchase Agreement. In 2019, the Company recovered a portion of the settlement through insurance coverage. The Company has provided certain standard indemnifications in connection with its Matrix stock subscription transaction whereby Mercury Fortuna Buyer, LLC (“Subscriber”), Providence and Matrix entered into a stock subscription agreement (the “Subscription Agreement”), dated August 28, 2016. The representations and warranties made by the Company in the Subscription Agreement ended January 19, 2018; however, certain fundamental representations survived through October 19, 2019. The covenants and agreements of the parties to be performed prior to the closing ended January 19, 2018, and all other covenants and agreements survived until the expiration of the applicable statute of limitations in the event of a breach, or for such lesser periods specified therein. The Company is not aware of any indemnification liabilities with respect to Matrix that require accrual at September 30, 2020. The Company has provided certain standard indemnifications in connection with the sale of substantially all of its WD Services segment to Advanced Personnel Management Global Pty Ltd of Australia (“APM”), which closed on December 21, 2018. The non-title warranties made by the Company in the related Share Purchase Agreement survive for 18 months following the closing date, and the title-related warranties and tax warranties survive five years from the closing date (i.e., December 21, 2023). The Company is not aware of any indemnification liabilities with respect to the former WD Services segment that require accrual at September 30, 2020 . On May 9, 2018, the Company entered into a registration indemnification agreement with Coliseum Capital Partners, L.P., Coliseum Capital Partners II, L.P., Blackwell Partners, LLC - Series A and Coliseum Capital Co-Invest, L.P. (collectively, the “Coliseum Stockholders”), who as of September 30, 2020 collectively held approximately 12.7% of the Company’s outstanding common stock, pursuant to which the Company has agreed to indemnify the Coliseum Stockholders, and the Coliseum Stockholders have agreed to indemnify the Company, against certain matters relating to the registration of the selling stockholders’ securities for resale under the Securities Act of 1933, as amended (the “Securities Act”). Significant Lease Not Yet Commenced In August 2020, the Company entered into an 11-1/2 year operating lease agreement for new corporate office space in Denver, Colorado. The lease is expected to commence when construction of the asset is completed in the second quarter of 2021. Total estimated base rent payments over the life of the lease are approximately $29.7 million

Transactions with Related Parti

Transactions with Related Parties	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Transactions with Related Parties	Transactions with Related Parties As discussed in Note 10, Stock-Based Compensation and Similar Arrangements , on June 8, 2020, the Company entered into a Preferred Stock Conversion Agreement with Coliseum Capital Partners, L.P. and certain funds and accounts managed by Coliseum Capital Management, LLC. Pursuant to the Conversion Agreement, the Company purchased 369,120 shares of Series A Convertible Preferred Stock, par value $0.001 per share, in exchange for $209.88 in cash per share of Series A Preferred Stock, plus a cash amount equal to accrued but unpaid dividends on such shares of Series A Preferred Stock through the day prior to June 11, 2020. Further, the Holders converted 369,120 shares of Series A Preferred Stock into 925,567 shares of common stock, a cash payment equal to accrued but unpaid dividends on such shares of Series A Preferred Stock through June 11, 2020, and a cash payment of $8.82 per share of Series A Preferred Stock. The amount of accrued dividends paid pursuant to the Conversion Agreement was equal to $0.8 million. Further, on September 3, 2020, the Company elected to effect the conversion (the “Conversion”) of all of the outstanding Series A Convertible Preferred Stock. In accordance with the Preferred Stock Conversion Agreement dated June 8, 2020 (as amended), immediately prior to the Conversion, the Company repurchased 27,509 shares of Series A Preferred Stock from the Holders for a cash amount equal to $209.88 per share of Series A Preferred Stock and a cash amount equal to accrued but unpaid dividends on such shares through the day prior to the Conversion.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Acquisitions	Acquisitions On May 6, 2020, LogistiCare entered into an equity purchase agreement with the Seller and NMT, acquiring all of the outstanding capital stock. NMT’s contractual relationships, which are approximately 85% capitated, provide more than five million trips annually to approximately two million members on behalf of state Medicaid agencies and MCOs across twelve states. NMT was acquired for approximately $80.0 million in an all cash transaction. The transaction was accounted for as an asset acquisition in accordance with ASC 805, Business Combinations . The Company obtained an analysis from an independent third-party valuation specialist to assist in determining the purchase price allocation. The Company incurred transaction costs for the acquisition of $0.8 million during the nine months ended September 30, 2020. These costs were capitalized as a component of the purchase price. The consideration paid for the acquisition is as follows (in thousands): Value Consideration paid $ 80,000 Transaction costs 774 Restricted cash received (3,109) Net consideration $ 77,665 Restricted cash acquired was related to a security reserve for a contract. No liabilities were assumed. The fair value allocation of the net consideration is as follows (in thousands, except useful lives): Type Useful Life (yrs) Value Customer relationships Amortizable 6 $ 75,514 Trade names and trademarks Amortizable 3 2,151 $ 77,665

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations On December 21, 2018, the Company completed the sale of substantially all of the operating subsidiaries of its WD Services segment to APM and APM UK Holdings Limited, an affiliate of APM, except for the segment’s employment services operations in Saudi Arabia. The Company’s contractual counterparties in Saudi Arabia, including an entity owned by the Saudi Arabian government, assumed these operations beginning January 1, 2019. The Company is winding down its Saudi Arabian entity. On June 11, 2018, the Company entered into a Share Purchase Agreement to sell the shares of Ingeus France, its WD Services operation in France, for a de minimis amount. The sale was effective on July 17, 2018. On November 1, 2015, the Company completed the sale of its Human Services segment. During the three and nine months ended September 30, 2020 and 2019, the Company recorded additional expenses related to the Human Services segment, principally related to previously disclosed legal proceedings and professional fees. Results of Operations The following tables summarize the results of operations classified as discontinued operations for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three months ended September 30, 2020 Human Services WD Services Total Discontinued Operating expenses: General and administrative (income) expense $ (7) $ 160 $ 153 Total operating (income) expense (7) 160 153 Operating income (loss) 7 (160) (153) Income (loss) from discontinued operations before income taxes 7 (160) (153) (Provision) benefit for income taxes (2) 40 38 Income (loss) from discontinued operations, net of tax $ 5 $ (120) $ (115) Nine months ended September 30, 2020 Human Services Segment WD Services Segment Total Discontinued Operations Operating expenses: General and administrative expense $ 327 $ 470 $ 797 Total operating expense 327 470 797 Operating loss (327) (470) (797) Loss from discontinued operations before income taxes (327) (470) (797) Benefit for income taxes 62 117 179 Loss from discontinued operations, net of tax $ (265) $ (353) $ (618) Three months ended September 30, 2019 Human Services WD Services Total Discontinued Operating expenses: General and administrative (income) expense $ (12) $ 480 $ 468 Total operating (income) loss (12) 480 468 Operating income (loss) 12 (480) (468) Income (loss) from discontinued operations before income taxes 12 (480) (468) (Provision) benefit for income taxes (3) 45 42 Income (loss) from discontinued operations, net of tax $ 9 $ (435) $ (426) Nine months ended September 30, 2019 Human Services Segment WD Services Segment Total Discontinued Operations Operating expenses: General and administrative expense (income) $ 205 $ (1,617) $ (1,412) Total operating loss (income) 205 (1,617) (1,412) Operating (loss) income (205) 1,617 1,412 (Loss) income from discontinued operations before income taxes (205) 1,617 1,412 Benefit (provision) for income taxes 50 (922) (872) (Loss) income from discontinued operations, net of tax $ (155) $ 695 $ 540 Assets and liabilities The following table summarizes the carrying amounts of the major classes of assets and liabilities of discontinued operations in the condensed consolidated balance sheets as o f September 30, 2020 a nd December 31, 2019. Amounts represent the accounts of WD Services operations in Saudi Arabia, which were not sold as part of the WD Services sale (in thousands): September 30, 2020 December 31, 2019 Cash and cash equivalents $ 357 $ 155 Current assets of discontinued operations $ 357 $ 155 Accounts payable $ 41 $ 16 Accrued expenses 1,693 1,414 Current liabilities of discontinued operations $ 1,734 $ 1,430 Cash Flow Information There were $0.8 million in cash flow payments related to operating expenses for WD Services and Human Services Segment for the nine months ended September 30, 2020. There we

Segments

Segments	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segments	Segments The Company’s chief operating decision maker reviews financial performance and allocates resources based on two segments as follows: • NET Services - which operates primarily under the brands LogistiCare and Circulation, is the largest manager of NEMT programs for state governments and MCOs in the U.S and includes the Company’s activities for executive, accounting, finance, internal audit, tax, legal, certain strategic and development functions and the Company's now dissolved captive insurance company. • Matrix Investment ("Matrix") - which consists of a minority investment in Matrix, provides a broad array of assessment and care management services that improve health outcomes for individuals and financial performance for health plans. Matrix’s national network of community-based clinicians delivers in-home and on-site services while its fleet of mobile health clinics provides community-based care with advance diagnostic capabilities. The following tables set forth certain financial information from continuing operations attributable to the Company’s business segments (in thousands): Three months ended September 30, 2020 NET Services Matrix Total Service revenue, net $ 320,619 $ — $ 320,619 Service expense 235,543 — 235,543 General and administrative expense 34,441 — 34,441 Depreciation and amortization 7,301 — 7,301 Operating income $ 43,334 $ — $ 43,334 Equity in net income of investee $ — $ 10,325 $ 10,325 Investment in equity method investee $ — $ 141,292 $ 141,292 Total assets (continuing operations) $ 649,986 $ 141,292 $ 791,278 Nine months ended September 30, 2020 NET Services Matrix Total Service revenue, net $ 970,166 $ — $ 970,166 Service expense 764,310 — 764,310 General and administrative expense 86,435 — 86,435 Depreciation and amortization 17,199 — 17,199 Operating income $ 102,222 $ — $ 102,222 Equity in net income of investee $ — $ 12,200 $ 12,200 Investment in equity method investee $ — $ 141,292 $ 141,292 Total assets (continuing operations) $ 649,986 $ 141,292 $ 791,278 Three months ended September 30, 2019 NET Services Matrix Total Service revenue, net $ 393,385 $ — $ 393,385 Service expense 356,271 — 356,271 General and administrative expense 15,979 — 15,979 Depreciation and amortization 4,148 — 4,148 Operating income $ 16,987 $ — $ 16,987 Equity in net loss of investee $ — $ (3,188) $ (3,188) Investment in equity method investee $ — $ 154,532 $ 154,532 Total assets (continuing operations) $ 465,688 $ 154,532 $ 620,220 Nine months ended September 30, 2019 NET Services Matrix Total Service revenue, net $ 1,125,111 $ — $ 1,125,111 Service expense 1,042,717 — 1,042,717 General and administrative expense 52,241 — 52,241 Depreciation and amortization 12,976 — 12,976 Operating income $ 17,177 $ — $ 17,177 Equity in net loss of investee $ — $ (6,159) $ (6,159) Investment in equity method investee $ — $ 154,532 $ 154,532 Total assets (continuing operations) $ 465,688 $ 154,532 $ 620,220

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On September 28, 2020, the Company entered into a stock purchase agreement (the “Simplura Purchase Agreement”) with OEP AM, Inc., a Delaware corporation, doing business as Simplura Health Group. Pursuant to the Simplura Purchase Agreement, the Company plans to acquire all of the issued and outstanding capital stock of Simplura for $575.0 million in cash, subject to certain adjustments, including adjustments based on a determination of net working capital, cash, transaction expenses and indebtedness, as provided in the Simplura Purchase Agreement. The Company intends to close the transaction in the fourth quarter of 2020. Founded in 1955, Simplura is a home care services provider offering placements of personal care assistants, home health aides, and skilled nurses for senior citizens, disabled adults and other high-needs patients. Simplura operates from its headquarters in Valley Stream, New York, with approximately 57 branches across seven states, including in several of the nation’s largest home care markets. As of June 30, 2020, Simplura had approximately 14,000 trained caregivers throughout all locations serving, on average, approximately 12,500 patients and providing approximately 21 million hours of patient care annually. Simplura’s services are reimbursed by Medicaid, other governmental payors, and major insurance carriers. On October 22, 2020, the Company agreed to issue and sell $500.0 million in aggregate principal amount of senior notes due on November 15, 2025, which will bear interest at a rate of 5.875% per annum (the “notes”). Completion of the notes offering occurred on November 4, 2020, and the gross proceeds of the sale of the notes were deposited into an escrow account for the benefit of the holders of the notes pending consummation of the Simplura Acquisition. The Company intends to use the proceeds from the notes, together with borrowings under its credit facility and cash on hand, to (i) pay the consideration in connection with the Simplura Acquisition, (ii) repay in full substantially all debt for borrowed money of the Simplura Group (together with the termination of all commitments and the release and discharge of all security interests and guarantees related thereto), and (iii) pay fees and expenses incurred in connection with the transactions.

Significant Accounting Polici_2

Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting	Basis of Presentation The Company follows accounting standards set by the Financial Accounting Standards Board (“FASB”). The FASB establishes accounting principles generally accepted in the United States (“GAAP”). Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. References to GAAP issued by the FASB in these footnotes are to the FASB Accounting Standards Codification (“ASC”), which serves as the single source of authoritative accounting and applicable reporting standards to be applied for non-governmental entities. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for the fair presentation of the results of the interim periods have been included. The Company has made estimates relating to the reporting of assets and liabilities, revenues and expenses and certain disclosures in the preparation of these unaudited condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020. Management has evaluated events and transactions that occurred after the balance sheet date and through the date these unaudited condensed consolidated financial statements were filed with the SEC and considered the effect of such events in the preparation of these condensed consolidated financial statements. The condensed consolidated balance sheet at December 31, 2019 included in this Form 10-Q has been derived from audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements contained herein should be read in conjunction with the audited financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The Company accounts for its investment in Matrix using the equity method, as the Company does not control the decision-making process or business management practices of Matrix. While the Company has access to certain information and performs certain procedures to review the reasonableness of information, the Company relies on the management of Matrix to provide accurate financial information prepared in accordance with GAAP. The Company receives audit reports relating to such financial information from Matrix’s independent auditors on an annual basis. The Company is not aware of any errors in or possible misstatements of the financial information provided by Matrix that would have a material effect on the Company’s condensed consolidated financial statements. See Note 5, Equity Investment , for further information. Uncertainties due to COVID-19 In December 2019, an outbreak of a new strain of a coronavirus causing a coronavirus disease ("COVID-19"), began in Wuhan, Hubei Province, China. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. COVID-19, as well as measures taken by governmental authorities and private actors to limit the spread of this virus, has and is likely to continue to interfere with the ability of the Company's employees, suppliers, transportation providers and other business providers to carry out their assigned tasks at ordinary levels of performance relative to the conduct of the Company’s business which may cause the Company to materially curtail certain business operations. While the Company is monitoring the impact of COVID-19 on its business and financial results, at this time the Company is unable to accurately predict the extent to which the COVID-19 pandemic impacts its business, operations and financial results. On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which includes modifications to the limitation on business interest expense and net operating loss provisions, and provides a delay in the payment of employer federal payroll taxes during 2020 after the date of enactment. Due to the favorable impact of the CARES Act on the Company’s 2018 U.S. net operating losses ("NOLs"), the effective tax rate of 17.6% was lower than the U.S. federal statutory rate of 21.0% for the nine months ended September 30, 2020. The 27.0% effective tax rate for the three months ended September 30, 2020 was not impacted by the CARES Act. See Note 12, Income Taxes , for further information. The accompanying unaudited condensed consolidated financial statements reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and reported amounts of revenue and expenses. It is possible that the Company's assumptions and estimates may materially change due to these uncertainties. Reclassifications During the nine months ended September 30, 2020, the Company has separately classified the reduction of right-of-use assets in its unaudited condensed consolidated statement of cash flows and conformed the prior period.
New Accounting Pronouncements	The Company adopted the following accounting pronouncements during the nine months ended September 30, 2020: In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”). The amendments in ASU 2016-13 superseded much of the existing guidance for reporting credit losses for assets held at amortized cost basis and available for sale debt securities. The amendments in ASU 2016-13 affected loans, debt securities, trade receivables, net investments in leases, off-balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The Company adopted ASU 2016-13 on January 1, 2020. As of September 30, 2020, this guidance did not have a material impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”) which removed, modified, and added additional disclosures related to fair value measurements. The Company adopted ASU 2018-13 on January 1, 2020. As of September 30, 2020, this guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (“ASU 2018-15”). ASU 2018-15 aligned the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company elected to apply the prospective transition approach and therefore applied the transition requirements to any eligible costs incurred after adoption. The Company adopted ASU 2018-15 on January 1, 2020. As of September 30, 2020, the Company has not incurred any material implementation costs associated with new service contracts since the date of adoption. In February 2020, the FASB issued ASU No. 2020-02, Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) ("ASU 2020-02"). ASU 2020-02 provides interpretive guidance on methodologies and supporting documentation for measuring credit losses, with a focus on the documentation the SEC would normally expect registrants engaged in lending transactions to prepare and maintain to support estimates of current expected credit losses for loan transactions. The Company adopted ASU 2020-02 on February 6, 2020, as the ASU was effective upon issuance. As of September 30, 2020, this guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments ("ASU 2020-03") to make improvements to ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") . Public business entities that meet the definition of an SEC filer, excluding eligible smaller reporting companies as defined by the SEC, should adopt ASU 2020-03 during 2020. The Company adopted ASU 2020-03 on April 1, 2020. This guidance did not have an impact on the unaudited condensed consolidated financial statements or disclosures nor is it expected to have a material impact in the future. Recent accounting pronouncements that the Company has yet to adopt are as follows: In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). The ASU removes certain exceptions to the general principles in ASC 740, Income Taxes , and also clarifies and amends existing guidance to improve consistent application. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company is currently evaluating the impact of this ASU, but does not expect a material impact to the financial statements upon adoption. In January 2020, the FASB issued ASU 2020-01, Clarifying the Interactions Between Topic 321, Topic 323, and Topic 81 5 ("ASU 2020-01"), to clarify the interaction among the accounting standards for equity securities, equity method investments and certain derivatives. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the impact ASU 2020-01 will have on its consolidated financial statements or disclosures; however, does not expect the adoption to have a material impact. In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04") which provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships, and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discontinued due to reference rate reform. The relief granted in ASC 848, Reference Rate Reform ("ASC 848"), is applicable only to legacy contracts if the amendments made to the agreements are solely for reference rate reform activities. The provisions of ASC 848 must be applied for all transactions other than derivatives, which may be applied at a hedging relationship level. Entities may apply the provisions as of the beginning of the reporting period when the election is made (i.e. as early as the first quarter 2020). Unlike other topics, the provisions of this update are only available until December 31, 2022, when the reference rate replacement activity is expected to be completed. The Company is currently evaluating the impact ASU 2020-04 will have on its consolidated financial statements or disclosures; however, does not expect the adoption to have a material impact. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06") which addresses the complexity associated with applying generally accepted accounting principles (GAAP) for certain financial instruments with characteristics of liabilities and equity. The update limits the accounting models for convertible instruments resulting in fewer embedded conversion features being separately recognized from the host contract. Specifically, ASU 2020-06 removes from GAAP the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. As a result, after adopting the ASU’s guidance, entities will not separately present in equity an embedded conversion feature in such debt. ASU 2020-06 is effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods therein. The Company is currently evaluating the impact ASU 2020-06 will have on its consolidated financial statements or disclosures.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table summarizes disaggregated revenue from contracts with customers by contract type (in thousands): Three months ended September 30, 2020 2019 State Medicaid agency contracts $ 154,689 $ 196,891 Managed care organization contracts 165,930 196,494 Total Service revenue, net $ 320,619 $ 393,385 Capitated contracts $ 277,908 $ 334,549 Non-capitated contracts 42,711 58,836 Total Service revenue, net $ 320,619 $ 393,385 Nine months ended September 30, 2020 2019 State Medicaid agency contracts $ 486,964 $ 551,632 Managed care organization contracts 483,202 573,479 Total Service revenue, net $ 970,166 $ 1,125,111 Capitated contracts $ 832,490 $ 947,811 Non-capitated contracts 137,676 177,300 Total Service revenue, net $ 970,166 $ 1,125,111
Schedule of Accounts Receivable	The following table provides information about accounts receivable, net (in thousands): September 30, 2020 December 31, 2019 Accounts receivable $ 118,101 $ 124,868 Reconciliation contracts receivable 49,637 61,481 Allowance for doubtful accounts (2,794) (5,933) Accounts receivable, net $ 164,944 $ 180,416
Other Account Liabilities	The following table provides information about other accounts included on the accompanying condensed consolidated balance sheets (in thousands): September 30, 2020 December 31, 2019 Accrued contract payables, current, included in “Accrued expenses” (1) $ 88,347 $ 15,706 Long-term contract payables (2) 50,244 — Deferred revenue, current 681 227 Deferred revenue, long-term, included in “Other long-term liabilities” 629 758

Cash, Cash Equivalents and Re_2

Cash, Cash Equivalents and Restricted Cash (Tables)	9 Months Ended
	Sep. 30, 2020
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash, Cash Equivalents and Restricted Cash	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2020 2019 Cash and cash equivalents $ 183,277 $ 40,637 Restricted cash, current 3,182 833 Current assets of discontinued operations 357 250 Cash, cash equivalents and restricted cash $ 186,816 $ 41,720

Equity Investment (Tables)

Equity Investment (Tables)	9 Months Ended
	Sep. 30, 2020
Equity Method Investment, Summarized Financial Information [Abstract]
Income Statement and Balance Sheet Disclosure	Summary financial information for Matrix on a standalone basis is as follows (in thousands): September 30, 2020 December 31, 2019 Current assets $ 149,548 $ 64,221 Long-term assets 618,905 631,007 Current liabilities 65,808 31,256 Long-term liabilities 364,061 351,380 Three months ended September 30, 2020 2019 Revenue $ 140,728 $ 71,663 Operating income (loss) 35,489 (2,640) Net income (loss) 21,382 (6,906) Nine months ended September 30, 2020 2019 Revenue $ 292,699 $ 210,807 Operating income (loss) 49,074 (542) Net income (loss) 23,917 (15,054)

Prepaid Expenses and Other (Tab

Prepaid Expenses and Other (Tables)	9 Months Ended
	Sep. 30, 2020
Prepaid Expense and Other Assets, Current [Abstract]
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure	Prepaid expenses and other were comprised of the following (in thousands): September 30, 2020 December 31, 2019 Prepaid income taxes $ 8,105 $ 2,942 Prepaid insurance 3,277 1,317 Prepaid rent 849 868 Other prepaid expenses 8,035 5,815 Total prepaid expenses and other $ 20,266 $ 10,942

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2020
Accrued Liabilities, Current [Abstract]
Schedule of Accrued Liabilities	Accrued expenses consisted of the following (in thousands): September 30, 2020 December 31, 2019 Accrued compensation and related liabilities $ 28,470 $ 8,941 Accrued contract payables, current 88,347 15,706 Accrued cash settled stock-based compensation 10,021 3,282 Other accrued expenses 16,195 10,804 Total accrued expenses $ 143,033 $ 38,733

Restructuring and Related Reo_2

Restructuring and Related Reorganization Costs (Tables)	9 Months Ended
	Sep. 30, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	The summary of the liability for restructuring and related reorganization costs is as follows (in thousands): As of January 1, 2019 Costs Cash Payments As of December 31, 2019 Retention and personnel liability $ 1,956 $ 2,418 $ (4,374) $ — Other liability 398 1,308 (1,706) — Total $ 2,354 $ 3,726 $ (6,080) $ —

Stock-Based Compensation and _2

Stock-Based Compensation and Similar Arrangements (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Disclosure of Stock-based Compensation by Line Item	The following table reflects the amount of stock-based compensation, for share settled grants or awards, recorded in each financial statement line item for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Service expense $ 55 $ 162 $ 174 $ 488 General and administrative expense 1,122 693 2,775 3,759 Total stock-based compensation $ 1,177 $ 855 $ 2,949 $ 4,247
Schedule of Conversions of Stock	The following table summarizes the convertible preferred stock activity in 2020 (in thousands, except share count): Dollar Value Share Count Balance at January 1, 2020 $ 77,120 798,788 Conversion to common stock (572) (5,666) Conversion to common stock pursuant to Conversion Agreement (37,256) (369,120) Preferred stock redemption pursuant to Conversion Agreement (37,256) (369,120) Reduction of unamortized issuance cost 3,263 — Balance at June 30, 2020 $ 5,299 54,882 Conversion to common stock (2,763) (27,373) Preferred stock redemption pursuant to Conversion Agreement (2,777) (27,509) Reduction of unamortized issuance cost 241 — Balance at September 30, 2020 $ — —

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table details the computation of basic and diluted earnings per share (in thousands, except share and per share data): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Numerator: Net income $ 38,805 $ 8,154 $ 91,901 $ 7,024 Dividends on convertible preferred stock outstanding — (1,109) (1,171) (3,295) Dividends paid pursuant to the Conversion Agreement (27) — (817) — Consideration paid in excess of preferred cost basis pursuant to the Conversion Agreement (3,186) — (52,137) — Income allocated to participating securities (246) (941) (3,213) (499) Net income available to common stockholders $ 35,346 $ 6,104 $ 34,563 $ 3,230 Continuing operations $ 35,461 $ 6,473 $ 35,181 $ 2,762 Discontinued operations (115) (369) (618) 468 Net income available to common stockholders $ 35,346 $ 6,104 $ 34,563 $ 3,230 Denominator: Denominator for basic earnings per share -- weighted-average shares 14,026,039 12,993,934 13,367,605 12,956,222 Effect of dilutive securities: Common stock options 61,312 10,515 15,730 21,376 Restricted stock 46,553 — 32,009 — Denominator for diluted earnings per share -- adjusted weighted-average shares assumed conversion 14,133,904 13,004,449 13,415,344 12,977,598 Basic earnings (loss) per share: Continuing operations $ 2.53 $ 0.50 $ 2.63 $ 0.21 Discontinued operations (0.01) (0.03) (0.05) 0.04 Basic earnings per share $ 2.52 $ 0.47 $ 2.58 $ 0.25 Diluted earnings (loss) per share: Continuing operations $ 2.51 $ 0.50 $ 2.62 $ 0.21 Discontinued operations (0.01) (0.03) (0.05) 0.04 Diluted earnings per share $ 2.50 $ 0.47 $ 2.57 $ 0.25
Schedule of Antidilutive Securities	The following weighted-average shares were not included in the computation of diluted earnings per share as the effect of their inclusion would have been anti-dilutive: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Stock options to purchase common stock 3,481 420,846 170,076 499,611 Convertible preferred stock 38,851 799,969 487,576 800,983

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition	The consideration paid for the acquisition is as follows (in thousands): Value Consideration paid $ 80,000 Transaction costs 774 Restricted cash received (3,109) Net consideration $ 77,665
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The fair value allocation of the net consideration is as follows (in thousands, except useful lives): Type Useful Life (yrs) Value Customer relationships Amortizable 6 $ 75,514 Trade names and trademarks Amortizable 3 2,151 $ 77,665

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Summary of Operations Classified as Discontinued Operations	The following tables summarize the results of operations classified as discontinued operations for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three months ended September 30, 2020 Human Services WD Services Total Discontinued Operating expenses: General and administrative (income) expense $ (7) $ 160 $ 153 Total operating (income) expense (7) 160 153 Operating income (loss) 7 (160) (153) Income (loss) from discontinued operations before income taxes 7 (160) (153) (Provision) benefit for income taxes (2) 40 38 Income (loss) from discontinued operations, net of tax $ 5 $ (120) $ (115) Nine months ended September 30, 2020 Human Services Segment WD Services Segment Total Discontinued Operations Operating expenses: General and administrative expense $ 327 $ 470 $ 797 Total operating expense 327 470 797 Operating loss (327) (470) (797) Loss from discontinued operations before income taxes (327) (470) (797) Benefit for income taxes 62 117 179 Loss from discontinued operations, net of tax $ (265) $ (353) $ (618) Three months ended September 30, 2019 Human Services WD Services Total Discontinued Operating expenses: General and administrative (income) expense $ (12) $ 480 $ 468 Total operating (income) loss (12) 480 468 Operating income (loss) 12 (480) (468) Income (loss) from discontinued operations before income taxes 12 (480) (468) (Provision) benefit for income taxes (3) 45 42 Income (loss) from discontinued operations, net of tax $ 9 $ (435) $ (426) Nine months ended September 30, 2019 Human Services Segment WD Services Segment Total Discontinued Operations Operating expenses: General and administrative expense (income) $ 205 $ (1,617) $ (1,412) Total operating loss (income) 205 (1,617) (1,412) Operating (loss) income (205) 1,617 1,412 (Loss) income from discontinued operations before income taxes (205) 1,617 1,412 Benefit (provision) for income taxes 50 (922) (872) (Loss) income from discontinued operations, net of tax $ (155) $ 695 $ 540 Assets and liabilities The following table summarizes the carrying amounts of the major classes of assets and liabilities of discontinued operations in the condensed consolidated balance sheets as o f September 30, 2020 a nd December 31, 2019. Amounts represent the accounts of WD Services operations in Saudi Arabia, which were not sold as part of the WD Services sale (in thousands): September 30, 2020 December 31, 2019 Cash and cash equivalents $ 357 $ 155 Current assets of discontinued operations $ 357 $ 155 Accounts payable $ 41 $ 16 Accrued expenses 1,693 1,414 Current liabilities of discontinued operations $ 1,734 $ 1,430

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Financial Information Attributable to the Company's Business Segments	The following tables set forth certain financial information from continuing operations attributable to the Company’s business segments (in thousands): Three months ended September 30, 2020 NET Services Matrix Total Service revenue, net $ 320,619 $ — $ 320,619 Service expense 235,543 — 235,543 General and administrative expense 34,441 — 34,441 Depreciation and amortization 7,301 — 7,301 Operating income $ 43,334 $ — $ 43,334 Equity in net income of investee $ — $ 10,325 $ 10,325 Investment in equity method investee $ — $ 141,292 $ 141,292 Total assets (continuing operations) $ 649,986 $ 141,292 $ 791,278 Nine months ended September 30, 2020 NET Services Matrix Total Service revenue, net $ 970,166 $ — $ 970,166 Service expense 764,310 — 764,310 General and administrative expense 86,435 — 86,435 Depreciation and amortization 17,199 — 17,199 Operating income $ 102,222 $ — $ 102,222 Equity in net income of investee $ — $ 12,200 $ 12,200 Investment in equity method investee $ — $ 141,292 $ 141,292 Total assets (continuing operations) $ 649,986 $ 141,292 $ 791,278 Three months ended September 30, 2019 NET Services Matrix Total Service revenue, net $ 393,385 $ — $ 393,385 Service expense 356,271 — 356,271 General and administrative expense 15,979 — 15,979 Depreciation and amortization 4,148 — 4,148 Operating income $ 16,987 $ — $ 16,987 Equity in net loss of investee $ — $ (3,188) $ (3,188) Investment in equity method investee $ — $ 154,532 $ 154,532 Total assets (continuing operations) $ 465,688 $ 154,532 $ 620,220 Nine months ended September 30, 2019 NET Services Matrix Total Service revenue, net $ 1,125,111 $ — $ 1,125,111 Service expense 1,042,717 — 1,042,717 General and administrative expense 52,241 — 52,241 Depreciation and amortization 12,976 — 12,976 Operating income $ 17,177 $ — $ 17,177 Equity in net loss of investee $ — $ (6,159) $ (6,159) Investment in equity method investee $ — $ 154,532 $ 154,532 Total assets (continuing operations) $ 465,688 $ 154,532 $ 620,220

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Effective income tax rate	27.00%	37.30%	17.60%	37.80%
Matrix
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Equity method investment, ownership percentage	43.60%		43.60%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (NET Services) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Total Service revenue, net	$ 320,619	$ 393,385	$ 970,166	$ 1,125,111
NET Services
Disaggregation of Revenue [Line Items]
Total Service revenue, net	320,619	393,385	970,166	1,125,111
NET Services | State Medicaid agency contracts
Disaggregation of Revenue [Line Items]
Total Service revenue, net	154,689	196,891	486,964	551,632
NET Services | Managed care organization contracts
Disaggregation of Revenue [Line Items]
Total Service revenue, net	165,930	196,494	483,202	573,479
NET Services | Capitated contracts
Disaggregation of Revenue [Line Items]
Total Service revenue, net	277,908	334,549	832,490	947,811
NET Services | Non-capitated contracts
Disaggregation of Revenue [Line Items]
Total Service revenue, net	$ 42,711	$ 58,836	$ 137,676	$ 177,300

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Deferred Revenue
Revenue recognized			$ 200	$ 400
NET Services
Deferred Revenue
Performance obligation satisfied in previous period	$ 600	$ 15,300	$ 400	$ 8,500

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Accounts receivable	$ 118,101	$ 124,868
Reconciliation contracts receivable	49,637	61,481
Allowance for doubtful accounts	(2,794)	(5,933)
Accounts receivable, net	$ 164,944	$ 180,416

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of Other Accounts (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Accrued contract payables, current, included in “Accrued expenses” (1)	$ 88,347	$ 15,706
Long-term contract payables (2)	50,244	0
Deferred revenue, current	681	227
Deferred revenue, long-term, included in “Other long-term liabilities”	$ 629	$ 758

Cash, Cash Equivalents and Re_3

Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	$ 183,277	$ 61,365	$ 40,637
Restricted cash	3,182	153	833
Current assets of discontinued operations	357	$ 155	250
Cash, cash equivalents and restricted cash	$ 186,816		$ 41,720

Equity Investment - Narrative (

Equity Investment - Narrative (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Equity investment	$ 141,292,000	$ 130,869,000
Matrix
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	43.60%	43.60%
Impairment	$ 0	$ 55,100,000
Equity investment	$ 141,300,000	$ 130,900,000

Equity Investment - Summary of

Equity Investment - Summary of Financial Information for Matrix (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Schedule of Investments [Line Items]
Current assets	$ 379,336						$ 379,336		$ 256,427
Current liabilities	270,594						270,594		150,186
Service revenue, net	320,619			$ 393,385			970,166	$ 1,125,111
Operating income (loss)	43,334			16,987			102,222	17,177
Net income (loss)	38,805	$ 36,998	$ 16,098	8,154	$ (1,712)	$ 582	91,901	7,024
Matrix
Schedule of Investments [Line Items]
Current assets	149,548						149,548		64,221
Long-term assets	618,905						618,905		631,007
Current liabilities	65,808						65,808		31,256
Long-term liabilities	364,061						364,061		$ 351,380
Service revenue, net	140,728			71,663			292,699	210,807
Operating income (loss)	35,489			(2,640)			49,074	(542)
Net income (loss)	$ 21,382			$ (6,906)			$ 23,917	$ (15,054)

Prepaid Expenses and Other (Det

Prepaid Expenses and Other (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid income taxes	$ 8,105	$ 2,942
Prepaid insurance	3,277	1,317
Prepaid rent	849	868
Other prepaid expenses	8,035	5,815
Total prepaid expenses and other	$ 20,266	$ 10,942

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accrued Liabilities, Current [Abstract]
Accrued compensation and related liabilities	$ 28,470	$ 8,941
Accrued contract payables, current	88,347	15,706
Accrued cash settled stock-based compensation	10,021	3,282
Other accrued expenses	16,195	10,804
Total accrued expenses	$ 143,033	$ 38,733

Restructuring and Related Reo_3

Restructuring and Related Reorganization Costs - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring cost					$ 13,100,000
Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 700,000
Corporate Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring cost		$ 600,000		$ 3,700,000
Severance costs	$ 0		0		3,726,000
Restructuring reserve	$ 0		$ 0		0	$ 2,354,000
Corporate Restructuring Plan | Retention and Personnel Costs
Restructuring Cost and Reserve [Line Items]
Restructuring cost		100,000		2,400,000	7,500,000
Severance costs					2,418,000
Restructuring reserve					0	1,956,000
Corporate Restructuring Plan | Acceleration of Stock-Based Compensation
Restructuring Cost and Reserve [Line Items]
Restructuring cost		0		300,000	2,000,000
Corporate Restructuring Plan | Accelerated Depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring cost		0		200,000	700,000
Corporate Restructuring Plan | Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring cost		$ 500,000		$ 800,000	2,800,000
Severance costs					1,308,000
Restructuring reserve					$ 0	$ 398,000

Restructuring and Related Reo_4

Restructuring and Related Reorganization Costs - Reserve (Details) - Corporate Restructuring Plan - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Restructuring Reserve [Roll Forward]
Balance at beginning of period		$ 0	$ 2,354,000
Costs Incurred	$ 0	0	3,726,000
Cash Payments			(6,080,000)
Balance at end of period	$ 0	0	0
Retention and personnel liability
Restructuring Reserve [Roll Forward]
Balance at beginning of period		0	1,956,000
Costs Incurred			2,418,000
Cash Payments			(4,374,000)
Balance at end of period			0
Other liability
Restructuring Reserve [Roll Forward]
Balance at beginning of period		$ 0	398,000
Costs Incurred			1,308,000
Cash Payments			(1,706,000)
Balance at end of period			$ 0

Debt (Details)

Debt (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	May 06, 2020
Line of Credit Facility [Line Items]
Line of credit facility, outstanding	$ 0
Letters of credit outstanding, amount	16,900,000
Remaining borrowing capacity	208,100,000
Line of credit facility additional maximum borrowing capacity	75,000,000
Credit Facility, Fourth Amendment, Term Loan Tranche
Line of Credit Facility [Line Items]
Line of credit available	$ 40,000,000	$ 25,000,000
Credit Facility, Second Amendment, Term Loan Tranche | Minimum
Line of Credit Facility [Line Items]
Unused capacity, commitment fee percentage	0.35%
Credit Facility, Second Amendment, Term Loan Tranche | Maximum
Line of Credit Facility [Line Items]
Unused capacity, commitment fee percentage	0.50%
Credit Facility, Eighth Amendment, Term Loan Tranche | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Base rate for variable rate	1.00%
Credit Facility, Eighth Amendment, Term Loan Tranche | Minimum | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Basis spread on variable rate	2.25%
Credit Facility, Eighth Amendment, Term Loan Tranche | Minimum | Base Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.25%
Credit Facility, Eighth Amendment, Term Loan Tranche | Maximum | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Basis spread on variable rate	3.50%
Credit Facility, Eighth Amendment, Term Loan Tranche | Maximum | Base Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	2.50%
Revolving Credit Facility
Line of Credit Facility [Line Items]
Debt amount	$ 225,000,000	$ 200,000,000
Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Unused capacity, commitment fee percentage	2.25%
Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Unused capacity, commitment fee percentage	3.50%

Stock-Based Compensation and _3

Stock-Based Compensation and Similar Arrangements - Stock-based Compensation Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 1,177	$ 855	$ 2,949	$ 4,247
Service expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	55	162	174	488
General and administrative expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 1,122	$ 693	$ 2,775	$ 3,759

Stock-Based Compensation and _4

Stock-Based Compensation and Similar Arrangements - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 11, 2020	Jun. 08, 2020	Sep. 30, 2020	Sep. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Sep. 03, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)			358,953				358,953
Weighted-average exercise price (in usd per share)			$ 63.02				$ 63.02
Stock equivalent units outstanding (in shares)			3,862				3,862
Stock option equivalent units outstanding (in shares)			200,000				200,000
Temporary equity, shares outstanding (in shares)			798,788				798,788		798,788
Temporary equity, par (in usd per share)			$ 0.001				$ 0.001		$ 0.001
Accounting Standards Update [Extensible List]									us-gaap:AccountingStandardsUpdate201711Member
Retained earnings			$ (221,509)				$ (221,509)		$ (183,733)
Convertible shares (in shares)							0
Cumulative Effect, Period of Adoption, Adjustment
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Retained earnings			$ (52,100)				$ (52,100)
Series A Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Temporary equity, shares outstanding (in shares)		369,120,000
Temporary equity, par (in usd per share)		$ 0.001
Cash paid, per share (in usd per share)		209.88
Cash payment for shares (in usd per share)		$ 8.82
Treasury Stock, Preferred, Shares										27,509
Preferred Stock, Redemption Price Per Share										$ 209.88
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion to common stock (in shares)	925,567	2.5075	27,373,000			5,666,000
Convertible Preferred Stock, Shares Issued upon Conversion										2.5075
Management Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fixed payment					$ 12,000				2,700
Deferred compensation liability			$ 1,800				$ 1,800		1,100
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of unvested RSAs outstanding (in shares)			55,469				55,469
Weighted-average grant date fair value (in usd per share)			$ 62.78				$ 62.78
Stock Equivalent Unit Awards and Stock Option Equivalent Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of unvested RSAs outstanding (in shares)			46,021				46,021
Weighted-average grant date fair value (in usd per share)			$ 63.17				$ 63.17
Stock Equivalent Unit Awards and Stock Option Equivalent Units | Accrued Expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Liability for unexercised cash settled share-based payment awards			$ 10,000				$ 10,000		$ 3,300
Stock Equivalent Unit Awards and Stock Option Equivalent Units | General and administrative expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense (benefit)			$ 2,900	$ 400			$ 6,900	$ (200)

Stock-Based Compensation and _5

Stock-Based Compensation and Similar Arrangements - Conversion of Stock (Details) - USD ($) $ in Thousands	Jun. 11, 2020	Jun. 08, 2020	Sep. 30, 2020	Jun. 30, 2020
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Preferred stock, value, issued, beginning balance			$ 5,299	$ 77,120
Reduction of unamortized issuance cost			241	3,263
Preferred stock, value, issued, ending balance			$ 0	$ 5,299
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Preferred stock, shares outstanding, beginning balance (in shares)			54,882,000	798,788,000
Preferred stock, shares outstanding, ending balance (in shares)			0	54,882,000
Common Stock
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Conversion to common stock pursuant to Conversion Agreement			$ (2,763)	$ (572)
Conversion of stock, amount converted				$ (37,256)
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Conversion to common stock (in shares)	(925,567)	(2.5075)	(27,373,000)	(5,666,000)
Conversion of stock, shares converted (in shares)				(369,120,000)
Redeemable Preferred Stock
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Conversion of stock, amount converted			$ (2,777)	$ (37,256)
Increase (Decrease) in Convertible Preferred Stock [Roll Forward]
Conversion of stock, shares converted (in shares)			(27,509,000)	(369,120,000)

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Numerator:
Net income (loss)	$ 38,805	$ 36,998	$ 16,098	$ 8,154	$ (1,712)	$ 582	$ 91,901	$ 7,024
Dividends on convertible preferred stock outstanding	0			(1,109)			(1,171)	(3,295)
Consideration paid in excess of preferred cost basis pursuant to the Conversion Agreement	(3,186)			0			(52,137)	0
Income allocated to participating securities	(246)			(941)			(3,213)	(499)
Net income available to common stockholders	$ 35,346			$ 6,104			$ 34,563	$ 3,230
Denominator:
Denominator for basic earnings per share -- weighted-average shares	14,026,039			12,993,934			13,367,605	12,956,222
Effect of dilutive securities:
Denominator for diluted earnings per share -- adjusted weighted-average shares assumed conversion (in shares)	14,133,904			13,004,449			13,415,344	12,977,598
Basic earnings (loss) per share:
Continuing operations (in dollars per share)	$ 2.53			$ 0.50			$ 2.63	$ 0.21
Discontinued operations (in dollars per share)	(0.01)			(0.03)			(0.05)	0.04
Basic earnings per common share (in dollars per share)	2.52			0.47			2.58	0.25
Diluted earnings (loss) per share:
Continuing operations (in dollars per share)	2.51			0.50			2.62	0.21
Discontinued operations (in dollars per share)	(0.01)			(0.03)			(0.05)	0.04
Diluted (loss) earnings per common share (in dollars per share)	$ 2.50			$ 0.47			$ 2.57	$ 0.25
Preferred Stock Conversion Agreement
Numerator:
Dividends paid pursuant to the Conversion Agreement	$ (27)			$ 0			$ (817)	$ 0
Common stock options
Effect of dilutive securities:
Common stock options (in shares)	61,312			10,515			15,730	21,376
Restricted stock
Effect of dilutive securities:
Common stock options (in shares)	46,553			0			32,009	0
Continuing operations
Numerator:
Net income available to common stockholders	$ 35,461			$ 6,473			$ 35,181	$ 2,762
Discontinued operations
Numerator:
Net income available to common stockholders	$ (115)			$ (369)			$ (618)	$ 468

Earnings Per Share - Schedule_2

Earnings Per Share - Schedule of Antidilutive Securities (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	3,481	420,846	170,076	499,611
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	38,851	799,969	487,576	800,983

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate	27.00%	37.30%	17.60%	37.80%
Proceeds from income tax refunds					$ 30,800
Income taxes receivable	$ 27,300		$ 27,300
Tax benefit				$ 11,000
Increase income taxes payable				$ 3,500
Income taxes receivable, amount collected	17,000		17,000
Income taxes receivable, current	$ 10,300		$ 10,300

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)numberOfLawsuits	Sep. 30, 2020numberOfLawsuits	Aug. 31, 2020
Loss Contingencies [Line Items]
Class action lawsuits | numberOfLawsuits	26	26
Non-title related warranty, term		18 months
Title-related warranty, term		5 years
Term of contract			11 years 6 months
Future estimated base rent payments | $	$ 29.7
Common Stock | Affiliated Entity | Stockholders
Loss Contingencies [Line Items]
Related party, percentage of stock in company	12.70%	12.70%

Transactions with Related Par_2

Transactions with Related Parties (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 11, 2020	Jun. 08, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Temporary equity, shares outstanding (in shares)			798,788			798,788		798,788
Temporary equity, par (in usd per share)			$ 0.001			$ 0.001		$ 0.001
Payments of dividends to related parties	$ 800
Series A Preferred Stock
Related Party Transaction [Line Items]
Temporary equity, shares outstanding (in shares)		369,120,000
Temporary equity, par (in usd per share)		$ 0.001
Cash paid, per share (in usd per share)		209.88
Cash payment for shares (in usd per share)		$ 8.82
Common Stock
Related Party Transaction [Line Items]
Conversion of stock, shares issued (in shares)	925,567	2.5075	27,373,000		5,666,000
Coliseum Capital Partners, L.P. | Preferred Stock Dividends Earned by Related Party
Related Party Transaction [Line Items]
Related party transaction amount			$ 30	$ 1,100		$ 1,900	$ 3,200

Acquisitions (Details)

Acquisitions (Details) - National MedTrans - USD ($) $ in Thousands	May 06, 2020	Sep. 30, 2020
Business Acquisition, Contingent Consideration [Line Items]
Consideration paid	$ 80,000
Transaction costs	$ 774	$ 800

Acquisitions - Consideration Tr

Acquisitions - Consideration Transferred (Details) - National MedTrans - USD ($) $ in Thousands	May 06, 2020	Sep. 30, 2020
Business Acquisition, Contingent Consideration [Line Items]
Consideration paid	$ 80,000
Transaction costs	774	$ 800
Restricted cash received	(3,109)
Net consideration	$ 77,665

Acquisitions - Fair Value of In

Acquisitions - Fair Value of Intangible Assets (Details) - National MedTrans $ in Thousands	May 06, 2020USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets acquired	$ 77,665
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired finite-lived intangible assets, weighted average useful life	6 years
Finite-lived intangible assets acquired	$ 75,514
Trade names and trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired finite-lived intangible assets, weighted average useful life	3 years
Finite-lived intangible assets acquired	$ 2,151

Discontinued Operations - Resul

Discontinued Operations - Results of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Income (loss) from discontinued operations, net of tax	$ (115)	$ (426)	$ (618)	$ 540
Discontinued Operations, Disposed of by Sale
Operating expenses:
General and administrative (income) expense	153	468	797	(1,412)
Total operating (income) loss	153	468	797	(1,412)
Operating income (loss)	(153)	(468)	(797)	1,412
Income (loss) from discontinued operations before income taxes	(153)	(468)	(797)	1,412
(Provision) benefit for income taxes	38	(42)	179	(872)
Income (loss) from discontinued operations, net of tax	(115)	(426)	(618)	540
Human Services | Discontinued Operations, Disposed of by Sale
Operating expenses:
General and administrative (income) expense	(7)	(12)	327	205
Total operating (income) loss	(7)	(12)	327	205
Operating income (loss)	7	12	(327)	(205)
Income (loss) from discontinued operations before income taxes	7	12	(327)	(205)
(Provision) benefit for income taxes	(2)	3	62	50
Income (loss) from discontinued operations, net of tax	5	9	(265)	(155)
WD Services | Discontinued Operations, Disposed of by Sale
Operating expenses:
General and administrative (income) expense	160	480	470	(1,617)
Total operating (income) loss	160	480	470	(1,617)
Operating income (loss)	(160)	(480)	(470)	1,617
Income (loss) from discontinued operations before income taxes	(160)	(480)	(470)	1,617
(Provision) benefit for income taxes	40	(45)	117	(922)
Income (loss) from discontinued operations, net of tax	$ (120)	$ (435)	$ (353)	$ 695

Discontinued Operations - Asset

Discontinued Operations - Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Current assets of discontinued operations	$ 357	$ 155	$ 250
Current liabilities of discontinued operations	1,734	1,430
WD Services | Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	357	155
Current assets of discontinued operations	357	155
Accounts payable	41	16
Accrued expenses	1,693	1,414
Current liabilities of discontinued operations	$ 1,734	$ 1,430

Discontinued Operations - Cash

Discontinued Operations - Cash Flow (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deferred income taxes	$ 12,612	$ 1,993
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash provided by (used in) discontinued operations	$ 800
Human Services | Discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deferred income taxes		$ 600

Segments - Narrative (Details)

Segments - Narrative (Details)	9 Months Ended
	Sep. 30, 2020segment
Segment Reporting [Abstract]
Number of operating segments	2

Segments - Segments (Details)

Segments - Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Segment Reporting Information [Line Items]
Service revenue, net	$ 320,619	$ 393,385	$ 970,166	$ 1,125,111
Service expense	235,543	356,271	764,310	1,042,717
General and administrative expense	34,441	15,979	86,435	52,241
Depreciation and amortization	7,301	4,148	17,199	12,976
Operating income	43,334	16,987	102,222	17,177
Equity in net income of investee	10,325	(3,188)	12,200	(6,159)
Equity investment	141,292		141,292		$ 130,869
Total assets (continuing operations)	791,635		791,635		$ 597,381
NET Services
Segment Reporting Information [Line Items]
Service revenue, net	320,619	393,385	970,166	1,125,111
Continuing operations
Segment Reporting Information [Line Items]
Service revenue, net	320,619	393,385	970,166	1,125,111
Service expense	235,543	356,271	764,310	1,042,717
General and administrative expense	34,441	15,979	86,435	52,241
Depreciation and amortization	7,301	4,148	17,199	12,976
Operating income	43,334	16,987	102,222	17,177
Equity in net income of investee	10,325	(3,188)	12,200	(6,159)
Equity investment	141,292	154,532	141,292	154,532
Total assets (continuing operations)	791,278	620,220	791,278	620,220
Continuing operations | NET Services
Segment Reporting Information [Line Items]
Service revenue, net	320,619	393,385	970,166	1,125,111
Service expense	235,543	356,271	764,310	1,042,717
General and administrative expense	34,441	15,979	86,435	52,241
Depreciation and amortization	7,301	4,148	17,199	12,976
Operating income	43,334	16,987	102,222	17,177
Equity in net income of investee	0	0	0	0
Equity investment	0	0	0	0
Total assets (continuing operations)	649,986	465,688	649,986	465,688
Continuing operations | Matrix
Segment Reporting Information [Line Items]
Service revenue, net	0	0	0	0
Service expense	0	0	0	0
General and administrative expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Operating income	0	0	0	0
Equity in net income of investee	10,325	(3,188)	12,200	(6,159)
Equity investment	141,292	154,532	141,292	154,532
Total assets (continuing operations)	$ 141,292	$ 154,532	$ 141,292	$ 154,532

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event numberOfCaregivers in Thousands, $ in Thousands	3 Months Ended
	Dec. 31, 2020USD ($)	Nov. 05, 2020numberOfStatesnumberOfPatientHoursnumberOfBranchesnumberOfCaregiversnumberOfPatients	Nov. 04, 2020USD ($)
Simplura Health Group
Subsequent Event [Line Items]
Branches | numberOfBranches		57
Number of states in which entity operates | numberOfStates		7
Number of employees | numberOfCaregivers		14
Number of patients | numberOfPatients		12,500
Number of patient hours | numberOfPatientHours		21,000,000
Simplura Health Group | Forecast
Subsequent Event [Line Items]
Consideration paid	$ 575,000
Senior Notes
Subsequent Event [Line Items]
Debt amount			$ 500,000
Interest rate, stated percentage			5.875%